STANBIO LABORATORY
5 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (5)
- Inspections (1)
Devices registered here (1)
- Phosphomolybdate (Colorimetric), Inorganic PhosphorusProduct code CEO (opens in a new tab) · Class I · Clinical Chemistry · 21 CFR 862.1580
Recalls & enforcement
- Class IIOngoing2023-10-02Deterioration in the stability of the Test Strips results in diminished low-range detection capability and inability to meet linearity performance claims. The root cause of the stability deterioration in is identified as the change in material that caused a pH shift in the coatin…
- Class IITerminated2022-03-16The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)
- Class IIITerminated2021-07-12Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.
- Class IITerminated2018-02-13All patient serum samples yield a weakly positive test result.
- Class IITerminated2018-02-08The US prong (type A) adapter plate may crack, break, or detach and remain in the electrical outlet exposing live electrical contacts.
FDA inspections (1)
- NAI2017-06-30No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “STANBIO LABORATORY (FEI 1616487) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1616487-stanbio-laboratory/
Alerts for STANBIO LABORATORY
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.